Published by Frank Prenesti on 1st May 2026
(Sharecast News) - AstraZeneca shares fell on Friday after its experimental breast cancer treatment was given the thumbs down by an an advisory panel for the US Food and Drug Administration.
URL: http://www.digitallook.com/dl/news/story/35904673/...